```html

Idiopathic Thrombocytopenic Purpura (ITP) – A Patient‑Friendly Guide

Overview

Idiopathic thrombocytopenic purpura (ITP), also called immune thrombocytopenia, is an autoimmune disorder in which the body’s immune system mistakenly attacks and destroys platelets – the blood cells that help clot bleeding. When platelet counts fall below the normal range (< 150,000/µL), bruising, petechiae (tiny red dots), and bleeding can occur.

• Typical age groups:
  • Children 2–5 years old – often follows a viral infection and may resolve spontaneously.
  • Adults, especially women aged 20–40 years – chronic form is more common.
• Prevalence: Approximately 1–2 per 10,000 adults and 0.5 per 10,000 children in the United States (CDC, 2023). Women are affected about 2–3 times more often than men.
• Course: In children, ITP is usually acute and self‑limited, while in adults it tends to become chronic (lasting > 12 months).

Symptoms

Symptoms arise when platelet counts drop so low that normal clotting cannot occur. The severity of symptoms does not always correlate directly with the platelet number.

Skin‑related signs

• Petechiae: Small (1–2 mm) red or purple spots, often on the lower legs, arms, or trunk.
• Purpura: Larger (3–10 mm) bruises that may appear without trauma.
• Ecchymoses: Hematomas or “black‑eye” bruises that develop after minor bumps.
• Easy bruising: Bruises appear after minimal or no injury.

Mucosal bleeding

• Bleeding gums or spontaneous nosebleeds (epistaxis).
• Bleeding from the mouth or tongue after brushing.
• Heavy or prolonged menstrual periods (menorrhagia) in women.
• Blood in urine (hematuria) or stool (melena) – rare but signals very low platelets.

Other possible symptoms

• Fatigue – often related to anemia from occult bleeding.
• Headache or dizziness if intracranial bleeding occurs (medical emergency).
• Joint or muscle pain – sometimes present when ITP follows a viral infection.

Causes and Risk Factors

ITP is termed “idiopathic” because the exact trigger is unknown in many cases. Current research suggests an immune‑mediated process where antibodies target platelet surface proteins (e.g., GPIIb/IIIa) leading to their premature removal by the spleen.

Potential triggers

• Infections: Measles, rubella, hepatitis C, HIV, and recent viral upper‑respiratory infections.
• Medications: Heparin, quinine, certain antibiotics (e.g., sulfonamides), and antiepileptics can induce a secondary ITP.
• Vaccinations: Rarely reported after influenza or MMR vaccines; benefits far outweigh risk.
• Pregnancy: Hormonal and immunologic changes can unmask ITP.

Risk factors

• Female sex (especially child‑bearing age).
• History of autoimmune disease (e.g., lupus, rheumatoid arthritis).
• Recent viral infection or exposure to certain drugs.
• Family members with ITP (genetic predisposition is being investigated).

Diagnosis

Diagnosing ITP requires ruling out other causes of low platelets (thrombocytopenia). The process is systematic and includes history, physical exam, and laboratory testing.

Step‑by‑step diagnostic approach

1. Medical history & physical exam: Assess bleeding signs, recent infections, medication use, and family history.
2. Complete blood count (CBC) with peripheral smear: Isolated thrombocytopenia (low platelets) with normal red and white cells. The smear helps exclude platelet clumping or abnormal cells.
3. Bone‑marrow examination (rarely needed): Reserved for atypical presentations or when leukemia/aplastic anemia is suspected. In ITP, marrow shows normal or increased megakaryocytes.
4. Additional labs to exclude secondary causes:
   • Hepatitis B/C serologies, HIV test.
   • Antinuclear antibody (ANA) panel if autoimmune disease is suspected.
   • Lupus anticoagulant & antiphospholipid antibodies.
5. Imaging: Ultrasound or CT only if splenomegaly or internal bleeding is suspected.

Diagnostic criteria (per American Society of Hematology, 2022)

• Platelet count < 100,000/µL.
• No other evident cause for thrombocytopenia.
• Symptoms compatible with bleeding (optional).

Treatment Options

Treatment decisions balance platelet count, bleeding severity, patient age, comorbidities, and personal preferences. Not every patient requires immediate therapy; observation is reasonable for platelet counts > 30,000/µL without bleeding.

First‑line therapies

• Corticosteroids: Prednisone 1 mg/kg/day for 1–2 weeks, then taper. Works by suppressing antibody production.
• Intravenous immunoglobulin (IVIG): 1 g/kg daily for 1–2 days; raises platelets quickly (useful before surgery or in severe bleeding).
• Anti‑D immunoglobulin: For Rh‑positive, non‑splenectomized patients; similar rapid effect as IVIG.

Second‑line / chronic‑management options

• Rituximab: Anti‑CD20 monoclonal antibody; useful when steroids fail or cannot be tapered.
• Thrombopoietin receptor agonists (TPO‑RAs):
  • Eltrombopag (oral) – starting 50 mg daily.
  • Romiplostim (subcutaneous weekly injection).
  Both stimulate platelet production and are FDA‑approved for chronic ITP.
• Splenectomy: Surgical removal of the spleen; historically the most durable cure (70‑80 % remission) but carries lifelong infection risk.
• Immunosuppressants: Mycophenolate mofetil, azathioprine, or cyclosporine for refractory disease.

Supportive measures

• Tranexamic acid (oral or topical) for mucosal bleeding.
• Platelet transfusion – reserved for life‑threatening hemorrhage; transfused platelets are rapidly destroyed unless the underlying immune activity is controlled.
• Avoid aspirin, NSAIDs, and other antiplatelet agents unless specifically prescribed.

Lifestyle & adjunctive recommendations

• Maintain a balanced diet rich in vitamin K (leafy greens) – does not replace medication but supports overall hemostasis.
• Stay hydrated; dehydration can concentrate blood and increase bleeding risk.
• Use a soft toothbrush and avoid aggressive flossing to reduce gum bleeding.

Living with Idiopathic Thrombocytopenic Purpura

While ITP can be chronic, many people lead normal lives with appropriate management.

Daily self‑care tips

• Monitor platelet counts: Follow your hematologist’s schedule (often every 1–3 months).
• Watch for bleeding: Keep a diary of bruises, nosebleeds, gum bleeding, or changes in menstrual flow.
• Protect skin: Wear long sleeves, padded gloves for gardening or sports; use knee pads when cycling.
• Oral hygiene: Soft-bristled toothbrush, alcohol‑free mouthwash, floss gently.
• Travel considerations: Carry a copy of your diagnosis, medication list, and a small emergency kit (IVIG or corticosteroid “burst pack” if prescribed).

Emotional health

Living with a chronic autoimmune disorder can cause anxiety or depression. Seek support groups (e.g., ITP Foundation), counseling, or mindfulness programs. Evidence shows psychosocial support improves adherence and quality of life (Cleveland Clinic, 2022).

Prevention

Because ITP’s primary cause is immune dysregulation, true primary prevention is not yet possible. However, you can reduce secondary triggers and complications:

• Vaccinations: Stay up‑to‑date with flu, COVID‑19, and other recommended vaccines; they prevent infections that might precipitate ITP.
• Medication review: Inform all providers of your ITP diagnosis. Avoid over‑the‑counter NSAIDs or herbal products that may affect platelets unless cleared.
• Safe sex practices: Reduce risk of hepatitis C and HIV, both linked to secondary ITP.
• Regular medical follow‑up: Early detection of falling platelet counts allows prompt treatment before serious bleeding.

Complications

If left untreated or inadequately managed, ITP can lead to serious outcomes:

• Severe bleeding: Intracranial hemorrhage, gastrointestinal bleeding, or massive mucosal hemorrhage (life‑threatening).
• Chronic anemia: From ongoing micro‑bleeds, causing fatigue and reduced exercise tolerance.
• Infection risk after splenectomy: Encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis). Lifelong vaccination and prophylactic antibiotics are essential.
• Medication side effects: Long‑term steroids can cause osteoporosis, hyperglycemia, hypertension, and cataracts.
• Pregnancy complications: Low platelet counts can increase postpartum hemorrhage risk; coordinated care with obstetrics is crucial.

When to Seek Emergency Care

---

References (accessed July 2024):

• Mayo Clinic. “Immune thrombocytopenic purpura (ITP).” https://www.mayoclinic.org/diseases‑conditions/itp/
• American Society of Hematology. “Guidelines for the Management of ITP.” Blood, 2022.
• Centers for Disease Control and Prevention. “Thrombocytopenia.” https://www.cdc.gov/
• National Institutes of Health, National Heart, Lung, and Blood Institute. “Idiopathic thrombocytopenic purpura.” https://www.nhlbi.nih.gov/
• World Health Organization. “Bleeding disorders.” https://www.who.int/
• Cleveland Clinic. “Living with ITP: Lifestyle and Emotional Support.” 2022.

```